Bruyère Research Institute

Ottawa, Ontario K1R 6M1464

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, Cognitive Impairment, Dementia

Studies at this site

• A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease — Completed
• A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT) — Completed
• Neuro RX Gamma - Pivotal Phase — Paused